BFA
CRL icon

BlackRock Fund Advisors’s Charles River Laboratories CRL Stock Holding History

BlackRock Fund Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$144M Buy
1,895,542
+63,731
+3% +$4.84M 0.03% 902
2016
Q3 		$153M Buy
1,831,811
+77,014
+4% +$6.46M 0.03% 735
2016
Q2 		$145M Buy
1,754,797
+85,280
+5% +$7.02M 0.03% 702
2016
Q1 		$127M Sell
1,669,517
-14,644
-0.9% -$1.08M 0.03% 765
2015
Q4 		$135M Buy
1,684,161
+69,142
+4% +$4.99M 0.03% 733
2015
Q3 		$103M Buy
1,615,019
+1,234
+0.1% +$88.6K 0.03% 883
2015
Q2 		$114M Buy
1,613,785
+90,319
+6% +$6.68M 0.03% 889
2015
Q1 		$121M Buy
1,523,466
+156,222
+11% +$11.5M 0.03% 834
2014
Q4 		$87M Sell
1,367,244
-24,730
-2% -$1.55M 0.02% 1054
2014
Q3 		$83.2M Buy
1,391,974
+17,058
+1% +$976K 0.02% 991
2014
Q2 		$73.6M Buy
1,374,916
+62,346
+5% +$3.42M 0.02% 1129
2014
Q1 		$79.2M Sell
1,312,570
-69,507
-5% -$4.05M 0.02% 1041
2013
Q4 		$73.3M Buy
1,382,077
+103,569
+8% +$5.2M 0.02% 1094
2013
Q3 		$59.1M Buy
1,278,508
+59,395
+5% +$2.73M 0.02% 1193
2013
Q2 		$50M Buy
+1,219,113
New +$52.2M 0.02% 1204

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock Fund Advisors's CRL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Charles River Laboratories (CRL) stake by 3.5% in Q4 2016, buying an estimated $4.84M and bringing the position to 1,895,542 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #902.

BlackRock Fund Advisors first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $153M in Q3 2016. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Fund Advisors held 1,895,542 shares of Charles River Laboratories worth $144M as of Q4 2016.
  • BlackRock Fund Advisors bought 63,731 Charles River Laboratories shares in Q4 2016, an estimated $4.84M.
  • Charles River Laboratories made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #902 holding.
  • BlackRock Fund Advisors first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Charles River Laboratories position peaked at $153M in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.